In a report released yesterday, Lorenzo Biasio from Credit Suisse maintained a Hold rating on Pfizer (PFE – Research Report), with a price target of $54.00. The company's shares closed last Wednesday at $54.68, close to its 52-week high of $55.70. According to TipRanks.com, Biasio is a 4-star analyst with an average return of 8.2% and a 62.7% success rate. Biasio covers the Healthcare sector, focusing on stocks such as Coherus Biosciences, Intuitive Surgical, and Thermo Fisher. Pfizer has an analyst consensus of Moderate Buy, with a price target consensus of $51.77, which is a -1.3% downside from current levels.
https://www.tipranks.com/news/blurbs/pfizer-pfe-gets-a-hold-rating-from-credit-suisse-2?utm_source=advfn.com&utm_medium=referral
Pfizer (NYSE:PFE)
Gráfico Histórico do Ativo
De Dez 2021 até Jan 2022 Click aqui para mais gráficos Pfizer.
Pfizer (NYSE:PFE)
Gráfico Histórico do Ativo
De Jan 2021 até Jan 2022 Click aqui para mais gráficos Pfizer.